Every recall we track for SOMERSET THERAPEUTICS LLC — 9 in all — plus the complaints and injury reports the public filed about them.
Somerset Therapeutics recalls 10x10mL Dexamethasone Sodium Phosphate injection vials due to impurities detected during stability testing. These impurities could pose health risks if used beyond expiry.
Somerset Therapeutics recalls 10x5mL cisatracurium besylate injection vials due to subpotent product from assay results during stability testing. This may affect medical use safety.
Somerset Therapeutics recalls cisatracurium besylate injection vials with subpotent product due to assay results during stability testing. No specific remedy provided in the recall notice.
Somerset Therapeutics recalls 10x10mL Cisatracurium Besylate Injection vials due to subpotent product from stability testing. Affected lots may not be effective for medical use.
Somerset Therapeutics recalls 1% Atropine Sulf: Impurities may degrade product quality. Rx only, 5mL bottles. Check NDC 70069-716-01 and lot A240211.
SomerSET Therapeutics recalls Haloperidol decanoate injection 50mg/mL vials due to potential trace water contamination. This may cause adverse reactions. Check your vial lot numbers for affected batches.
